Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Topics:
Radiation Oncology
•
Gastrointestinal Cancers
How would you approach the management of a medically fit patient with synchronous locally advanced esophageal adenocarcinoma and resectable extrahepatic cholangiocarcinoma?
Related Questions
When using SBRT to treat unresectable pancreatic cancer after induction chemotherapy, do you treat elective lymph nodes?
Do you ever utilize short-course radiation when lateral pelvic (extra-mesorectal) lymph nodes are involved?
What are your top takeaways in GI Cancers from ASCO 2023?
Do you consider any "favorable" subset of patients with stage IV pancreatic cancer to be candidates for local pre-operative CRT and surgical resection?
How would you manage a positive margin after APR for a patient who received neoadjuvant CAPOX alone due to previous remote prostate cancer radiation?
Would you offer HAI (hepatic arterial infusion) or Y90 for colorectal liver metastases as a bridge to transplant?
How would you adjust your CTV for a locally advanced rectal cancer case with invasion of the prostate?
Would you alter radiation recommendations for a patient with locally advanced rectal cancer and a history of abdominopelvic lymphoma radiation 40 years ago?
How would you sequence treatment of a synchronous IC1 high-grade serous ovarian cancer and cT3N1 rectal cancer?
What are best practices for oncologists during the national platinum shortage?